DE1543766A1 - Verfahren zur Herstellung von Amiden von N-Acylcysteinen - Google Patents

Verfahren zur Herstellung von Amiden von N-Acylcysteinen

Info

Publication number
DE1543766A1
DE1543766A1 DE19661543766 DE1543766A DE1543766A1 DE 1543766 A1 DE1543766 A1 DE 1543766A1 DE 19661543766 DE19661543766 DE 19661543766 DE 1543766 A DE1543766 A DE 1543766A DE 1543766 A1 DE1543766 A1 DE 1543766A1
Authority
DE
Germany
Prior art keywords
formula
carbon atoms
alkyl
solution
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19661543766
Other languages
German (de)
English (en)
Inventor
Martin Tellis Alexander
Sheffner Aaron Leonard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson and Co LLC
Original Assignee
Mead Johnson and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson and Co LLC filed Critical Mead Johnson and Co LLC
Publication of DE1543766A1 publication Critical patent/DE1543766A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/04—Preparations for permanent waving or straightening the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Portable Nailing Machines And Staplers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
DE19661543766 1965-06-28 1966-06-24 Verfahren zur Herstellung von Amiden von N-Acylcysteinen Pending DE1543766A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US467674A US3340147A (en) 1965-06-28 1965-06-28 Amides of n-acylated cysteines
US467673A US3252866A (en) 1965-06-28 1965-06-28 2-hydrocarbon substituted-amido mercaptopropionamides in hair waving compositions and processes

Publications (1)

Publication Number Publication Date
DE1543766A1 true DE1543766A1 (de) 1970-01-02

Family

ID=27042136

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19661543766 Pending DE1543766A1 (de) 1965-06-28 1966-06-24 Verfahren zur Herstellung von Amiden von N-Acylcysteinen

Country Status (13)

Country Link
US (2) US3340147A (enExample)
AT (1) AT278735B (enExample)
BE (2) BE683281A (enExample)
BR (1) BR6680766D0 (enExample)
CH (2) CH472890A (enExample)
DE (1) DE1543766A1 (enExample)
DK (2) DK121762B (enExample)
FI (1) FI48344C (enExample)
FR (1) FR5630M (enExample)
GB (2) GB1144308A (enExample)
NL (2) NL6608251A (enExample)
NO (1) NO119638B (enExample)
SE (2) SE363095B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998050351A1 (en) * 1997-05-07 1998-11-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Berlin New cysteine derivatives, processes for their production, and pharmaceuticals containing them

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340147A (en) * 1965-06-28 1967-09-05 Mead Johnson & Co Amides of n-acylated cysteines
DE2349050C2 (de) * 1973-09-29 1985-06-05 Wella Ag, 6100 Darmstadt Verfahren und Mittel zur Herabsetzung der Wirkstoffkonzentration in kosmetischen Präparaten
US4061634A (en) * 1976-11-01 1977-12-06 The United States Of America As Represented By The Secretary Of Agriculture Sulfur-containing antimicrobial ester-amides
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
US5654301A (en) * 1985-02-15 1997-08-05 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US4992267A (en) * 1988-04-28 1991-02-12 Johnson Products Co., Inc. Hair straightening composition and system
US5165427A (en) * 1991-07-16 1992-11-24 Helene Curtis, Inc. Cysteinamide--containing permanent wave composition and method
US6420429B1 (en) * 1997-12-23 2002-07-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Brain targeted low molecular weight hydrophobic antioxidant compounds
US5874468A (en) * 1996-12-26 1999-02-23 Yissum Brain targeted low molecular weight hydrophobic antioxidant compounds
CN100453531C (zh) * 1998-10-09 2009-01-21 味之素株式会社 半胱氨酸衍生物
US7118736B2 (en) * 2001-02-22 2006-10-10 L'oreal Hair relaxer compositions comprising at least one hydroxide compound and at least one activating agent, and methods of using the same
US7468180B2 (en) * 2001-08-20 2008-12-23 L'oreal, S.A. Compositions comprising at least one hydroxide compound and at least one oxidizing agent, and methods to straighten curly hair
US7195755B2 (en) * 2001-08-20 2007-03-27 L'oreal S.A. Compositions comprising at least one hydroxide compound and at least one reducing agent, and methods for relaxing hair
FR2878435B1 (fr) * 2004-11-26 2009-04-03 Oreal Procede de defrisage des fibres keratiniques avec un moyen de chauffage et un agent denaturant
WO2016073931A1 (en) 2014-11-07 2016-05-12 The Johns Hopkins University Treatment of retinitis pigmentosa with n-acetylcysteine amide
US11268964B2 (en) 2014-11-11 2022-03-08 The Johns Hopkins University Biomarkers useful in the treatment of subjects having diseases of the eye
US11548851B2 (en) 2017-09-20 2023-01-10 Nacuity Pharmaceuticals, Inc. Method for preparation of n-acetyl cysteine amide and derivatives thereof
EP3684756A4 (en) * 2017-09-20 2020-10-28 NaCuity Pharmaceuticals, Inc. SYNTHESIS OF N-ACETYLCYSTEIN AMIDE AND ITS DERIVATIVES
US11091433B2 (en) 2017-09-20 2021-08-17 Nacuity Pharmaceutials, Inc. Method for preparation of N-acetyl cysteine amide and derivatives thereof
US20190135741A1 (en) 2017-11-09 2019-05-09 Nacuity Pharmaceuticals, Inc. Methods of Making Deuterium-Enriched N-acetylcysteine Amide (D-NACA) and (2R, 2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress
JP7631200B2 (ja) 2019-01-11 2025-02-18 ナキュイティ ファーマシューティカルズ， インク． 放射線皮膚炎の予防及び治療、並びに皮膚ライトニング、皮膚ホワイトニング、並びに皮膚改善のためのｎ－アセチルシステインアミド（ｎａｃａ）及び（２ｒ，２ｒ’）－３，３’－ジスルファンジイルビス（２－アセトアミドプロパンアミド）（ｄｉｎａｃａ）
AU2020206139A1 (en) 2019-01-11 2021-07-29 Nacuity Pharmaceuticals, Inc. Treatment of age-related macular degeneration, glaucoma, and diabetic retinopathy with N-acetylicysteine amide (NACA) or 2R,2R')-3-3'-disulfanediyl bis (2-acetamidopropanamide) (diNACA)
WO2020146660A1 (en) 2019-01-11 2020-07-16 Nacuity Pharmaceuticals, Inc. N-acetylcysteine amide (naca) and (2r,2r')-3-3'-disulfanediyl bis (2-acetamidopropanamide) (dinaca) for prevention and treatment of radiation pneumonitis and treatment of pulmonary function in cystic fibrosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340147A (en) * 1965-06-28 1967-09-05 Mead Johnson & Co Amides of n-acylated cysteines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998050351A1 (en) * 1997-05-07 1998-11-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Berlin New cysteine derivatives, processes for their production, and pharmaceuticals containing them

Also Published As

Publication number Publication date
GB1144308A (en) 1969-03-05
GB1114369A (en) 1968-05-22
US3252866A (en) 1966-05-24
AT278735B (de) 1970-02-10
NO119638B (enExample) 1970-06-15
DK121762B (da) 1971-11-29
DK115145B (da) 1969-09-08
FI48344B (enExample) 1974-05-31
SE344409B (enExample) 1972-04-17
BE683281A (enExample) 1966-12-28
NL6608251A (enExample) 1966-12-29
FR5630M (enExample) 1967-12-18
SE363095B (enExample) 1974-01-07
US3340147A (en) 1967-09-05
BR6680766D0 (pt) 1973-12-26
FI48344C (fi) 1974-09-10
CH503698A (de) 1971-02-28
BE683280A (enExample) 1966-12-28
NL6608252A (enExample) 1966-12-29
CH472890A (de) 1969-05-31

Similar Documents

Publication Publication Date Title
DE1543766A1 (de) Verfahren zur Herstellung von Amiden von N-Acylcysteinen
DE2810918C2 (de) Taurin-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1417343A1 (de) Verfahren zur Herstellung einer antibiotechnischen Zusammensetzung
DE2332878C2 (de) Salze von Cephalosporinen mit Arginin und Lysin, ihre Herstellung und injizierbare pharmazeutische Zubereitungen
DE1292656B (de) Piperazinderivate und ein Verfahren zu ihrer Herstellung
DE2140986A1 (de) 4- Amino-1 H-pyrazolo(3,4-d)pyrimidinderivate und deren Salze, Verfahren zur Herstellung solcher Substanzen und Arzneimittel mit einem Gehalt daran
DE2128941A1 (de) Neue Derivate des 2 Amino 5 Chlor Thiazols
DE1768655B2 (enExample)
DE2127734A1 (de) Neue Nitrofuranderivate und Verfahren zu ihrer Herstellung
DE1620177C3 (de) N-(2-Hydroxyäthyl)-piperazinocarboxymethyl-tetracyclin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2029305A1 (de) 1,4 Dialkyl 3,6 diphenylepi(thia , dithia oder -tetrathia) 2,5 piperazindione
DE2258930A1 (de) Antibakterielle mittel und verfahren zu deren herstellung
CH516593A (de) Verfahren zur Herstellung von neuen Estern von a-Aminobenzyl-penicillin
DE932675C (de) Verfahren zur Herstellung von Estern des Penicillins mit eine sekundaere Aminogruppe aufweisenden Alkoholen und von Salzen dieser Ester
DE2810774A1 (de) Ergotderivate, ihre verwendung und herstellung
AT286495B (de) Verfahren zur Herstellung von neuen Estern des α-Amino-benzylpenicillins
DE3516938A1 (de) Chinolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
DE1595876C (de) Aminomethylderivate von Rifamycin-SV und Verfahren zu ihrer Herstellung
CH506502A (de) Verfahren zur Herstellung von Amiden von N-Acyl-cysteinen
CH398613A (de) Verfahren zur Herstellung von neuen Piperazinen
DE1795735C3 (de) Rifamycin-SV-Derivate und Verfahren zu ihrer Herstellung
AT216145B (de) Verfahren zur Herstellung von neuen therapeutisch wertvollen Verbindungen
DE1770402C3 (de) N-Methyl-N-naphthyl-(1)-dithiocaTbamtnsäwre-2-benzoxazoVytester, Arzneimittel und Verfahren zu seiner Herstellung
DE2226063A1 (de) 2,2-Disubstituierte Aminoalkanamide, deren Säureanlagerungssalze und Verfahren zur Herstellung dieser Verbindungen
CH601299A5 (en) Pyrazino(1,2,3-ab)beta carbolines and homologues